1035 related items for PubMed ID: 19011009
1. Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.
Yang LP, Sun HL, Wu LM, Guo XJ, Dou HL, Tso MO, Zhao L, Li SM.
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2319-27. PubMed ID: 19011009
[Abstract] [Full Text] [Related]
2. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B, Sun JH, Xiang FF, Liu L, Li WJ.
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[Abstract] [Full Text] [Related]
3. Glial reactivity, an early feature of diabetic retinopathy.
Rungger-Brändle E, Dosso AA, Leuenberger PM.
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1971-80. PubMed ID: 10845624
[Abstract] [Full Text] [Related]
4. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ, Antonetti DA, Gardner TW.
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[Abstract] [Full Text] [Related]
5. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M.
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[Abstract] [Full Text] [Related]
6. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat.
Rollín R, Mediero A, Fernández-Cruz A, Fernández-Durango R.
Mol Vis; 2005 Mar 18; 11():216-24. PubMed ID: 15789000
[Abstract] [Full Text] [Related]
7. Expression of acute-phase response proteins in retinal Müller cells in diabetes.
Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P.
Invest Ophthalmol Vis Sci; 2005 Jan 18; 46(1):349-57. PubMed ID: 15623795
[Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW.
Invest Ophthalmol Vis Sci; 1997 Jan 18; 38(1):36-47. PubMed ID: 9008628
[Abstract] [Full Text] [Related]
9. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T, Matsubara A, Taniguchi K, Ogura Y.
Curr Eye Res; 2010 Feb 18; 35(2):146-54. PubMed ID: 20136425
[Abstract] [Full Text] [Related]
10. Upregulation of retinal neuronal MCP-1 in the rodent model of diabetic retinopathy and its function in vitro.
Dong N, Li X, Xiao L, Yu W, Wang B, Chu L.
Invest Ophthalmol Vis Sci; 2012 Nov 09; 53(12):7567-75. PubMed ID: 23010641
[Abstract] [Full Text] [Related]
11. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J, Zhou SX, Padillo E, Clarke KG, Gil DW.
Invest Ophthalmol Vis Sci; 2010 Feb 09; 51(2):1044-51. PubMed ID: 19710406
[Abstract] [Full Text] [Related]
12. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J, Zhou S, Padillo E, Clarke KG, Gil DW.
Invest Ophthalmol Vis Sci; 2007 Nov 09; 48(11):5152-9. PubMed ID: 17962468
[Abstract] [Full Text] [Related]
13. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C, Ward KW, Mazzon E, Cuzzocrea S, Drago F.
Invest Ophthalmol Vis Sci; 2009 Aug 09; 50(8):3846-52. PubMed ID: 19279317
[Abstract] [Full Text] [Related]
14. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N, Izumi-Nagai K, Oike Y, Koto T, Satofuka S, Ozawa Y, Yamashiro K, Inoue M, Tsubota K, Umezawa K, Ishida S.
Invest Ophthalmol Vis Sci; 2007 Sep 09; 48(9):4342-50. PubMed ID: 17724226
[Abstract] [Full Text] [Related]
15. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E, Poulaki V, Mitsiades N, Mitsiades CS, Miller JW, Gragoudas ES.
Invest Ophthalmol Vis Sci; 2009 Oct 09; 50(10):4898-904. PubMed ID: 19553613
[Abstract] [Full Text] [Related]
16. alpha-Crystallin downregulates the expression of TNF-alpha and iNOS by activated rat retinal microglia in vitro and in vivo.
Wu N, Wang YH, Zhao HS, Liu DN, Ying X, Yin ZQ, Wang Y.
Ophthalmic Res; 2009 Oct 09; 42(1):21-8. PubMed ID: 19478537
[Abstract] [Full Text] [Related]
17. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K, Jesmin S, Maeda S, Zaedi S, Shimojo N, Miyauchi T, Goto K.
Exp Biol Med (Maywood); 2006 Jun 09; 231(6):1090-4. PubMed ID: 16741055
[Abstract] [Full Text] [Related]
18. Normalization of retinal vascular permeability in experimental diabetes with genistein.
Nakajima M, Cooney MJ, Tu AH, Chang KY, Cao J, Ando A, An GJ, Melia M, de Juan E.
Invest Ophthalmol Vis Sci; 2001 Aug 09; 42(9):2110-4. PubMed ID: 11481279
[Abstract] [Full Text] [Related]
19. Sinomenine inhibits activation of rat retinal microglia induced by advanced glycation end products.
Wang AL, Li Z, Yuan M, Yu AC, Zhu X, Tso MO.
Int Immunopharmacol; 2007 Dec 05; 7(12):1552-8. PubMed ID: 17920532
[Abstract] [Full Text] [Related]
20. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas.
Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K.
Lab Invest; 1996 Apr 05; 74(4):819-25. PubMed ID: 8606491
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
